



A healthy mouth is necessary for optimal health and quality of life. However, oral health is often compromised in 
adults with chronic kidney disease (CKD). The aim of this review is to present the scientific foundations behind 
the connection between oral diseases and chronic kidney disease in adults, discuss common oral conditions and 
their systemic effects, investigate biological pathways through which oral infections affect the body, and provide 
guidelines for physicians/nephrologists. Prevalence of oral disease is increased in CKD, including periodontal disease, 
oral mucosal lesions, edentulousness, xerostomia, gingival overgrowth in immunosuppressed patients and potentially 
caries. There is moderate to strong evidence to support a negative impact of oral infections in CKD, particularly 
periodontal disease, with systemic inflammation, bacteraemia of oral origin, endothelial function and gut dysbiosis 
being potential pathways for this interaction. Poor oral health can be a hidden source of infection and has been 
associated with increased mortality in CKD patients. Elimination of potential foci for oral infections is crucial before 
renal transplantation. Frequent dental monitoring is essential for these patients and should be part of a multidisci-
plinary approach to manage CKD, with special attention to end-stage kidney disease.
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INtrODUctION
A healthy mouth is necessary for optimal health and 
quality of life [1]. However, oral health is often com-
promised by highly prevalent diseases such as caries, 
periodontal disease, mucosal lesions and occasionally 
oral cancer. Globally, over 3.5 billion people have oral 
disease. It is the most common non-communicable 
disease (NCD) worldwide, which constitutes a public 
health challenge, affecting most individuals throughout 
their lives [2]. Poor oral health is linked to a multitude of 
problems, which are not limited to the destruction of 
local tissues, pain, discomfort and impaired oral function, 
but it also affects the systemic environment, with the 
potential to increase inflammation in other body organs 
and systems [3]. 
Periodontal disease is a group of conditions that affect 
the tissues surrounding the teeth, with gingivitis and peri-
odontitis being the most common [4]. Elevated levels of 
pro-inflammatory cytokines and acute phase response 
mediators have been reported in the serum, plasma and 
gingival tissues of patients with periodontitis. A multitude 
of studies provide evidence on a potential relationship 
between periodontitis and general conditions, including 
chronic kidney disease (CKD), cardiovascular disease, 
diabetes, respiratory disease, rheumatoid arthritis, cancer, 
cognitive impairment and pregnancy outcomes [5].
Increased prevalence and severity of oral diseases have 
been reported in patients with CKD [6,7]. Considering 
that infection and inflammation originating from the oral 
cavity have the potential to contribute to systemic inflam-
mation, it is imperative to understand the impact of oral 
health on CKD and why it needs to be integrated into 
the overall management of CKD. 
The aim of this review of the literature is to present the 
scientific foundations of the connection between oral 
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diseases and CKD in adults, to discuss the most common 
oral conditions in CKD and their effect on the systemic 
environment, to investigate the biological pathways through 
which oral infections affect the body and to provide 
guidelines for physicians and nephrologists who treat 
patients with CKD. 
cOMMON OrAL cONDItIONs IN 
PAtIENts WItH cKD 
Periodontal disease
Periodontal disease is a term that includes disorders 
affecting the periodontium, that is, the tissues that surround 
the teeth, and are typically characterized by immune-
inflammatory response to bacterial pathogens in the oral 
biofilm [8]. Dental plaque or biofilm constitutes a reservoir 
of microorganisms, with over 500 microbial species that 
colonize different oral surfaces, including the epithelium, 
dental surfaces and the space below the gingival margin, 
known as gingival sulcus (in health) or pocket (in periodontal 
disease) [9].
The most prevalent diseases affecting the periodontium are 
gingivitis and periodontitis. Whereas gingivitis represents 
initial inflammation limited to gingival soft tissues, peri-
odontitis represents the progression of gingivitis, where the 
inflammatory process reaches deeper layers of connective 
and osseous tissues, leading to destruction of supporting 
structures that hold the teeth in place [10]. Periodontal 
disease can be challenging to identify by non-dental pro-
fessionals due to the typically discrete nature of signs and 
symptoms. 
Gingivitis can present the following signs and symptoms 
due to gingival inflammation [11]:
a.  Erythema, swelling of gingival tissues
b.  Soreness
c.   Gingival bleeding induced by eating, toothbrushing or 
flossing
d.  Bad breath, metallic or altered taste
e.  Difficulty eating.
According to severity and complexity of management, peri-
odontitis is classified as stage I (initial), stage II (moderate), 
stage III (severe with risk for tooth loss) or stage IV (severe 
with risk of loss of the dentition). It is also reported in terms 
of grades to describe progression as slow (grade A), 
moderate (grade B) and rapid (grade C) [12]. 
The signs and symptoms of periodontitis include all those 
described for gingivitis and a few additional ones [10]:
a.  Presence of calculus
b.  Receding gums; teeth can look longer
c.  Loose or separating teeth
d.  Change in the bite; change in the fit of partial dentures
e.  Pus between gingiva and teeth
f.  Pain when chewing.
Management of periodontal disease relies on controlling 
the biofilm and relevant modifiable risk factors. Scaling 
and root planning, also known as debridement, combined 
with effective oral hygiene procedures is the usual initial 
approach for periodontal treatment. If the mechanical 
treatment is not able to arrest disease progression, surgical 
and/or regenerative procedures can be performed, followed 
by regular professional maintenance. Systemic or local 
antibiotics are sometimes employed during periodontal 
treatment. For the majority of systemically healthy indivi-
duals, efficient daily oral hygiene habits are successful at 
limiting periodontal disease [2].
Periodontal disease in CKD patients
Several studies have reported an association between 
periodontal disease and CKD. Fisher et al. found that peri-
odontitis was independently associated with CKD and 
suggested a potential bidirectional link that can be related 
to diabetes and hypertension [13]. Duran and Erdemir 
reported that in patients undergoing haemodialysis, there 
was a correlation between worse periodontal conditions 
and duration of dialysis [14]. A link between elevated serum 
antibodies to periodontal pathogens and impaired kidney 
function was reported in a study by Kashirsagar et al.; the 
association remained significant after control for traditional 
risk factors [15]. The Third National Health and Nutrition 
Examination Survey (NHANES III) for the US population 
included 861 participants with CKD (6%). The 10-year all-
cause mortality rate in those participants increased from 
32% to 41% when periodontitis was present, characterizing 
a strong association between periodontitis and mortality in 
stage 3–5 CKD patients [16]. Periodontitis has been linked 
to reduced serum albumin in patients on haemodialysis 
therapy in two different studies, which can be a risk factor 
for increased mortality [17,18].
The association between periodontitis and CKD has been 
extensively explored in systematic reviews [19-23]. The 
first such review and meta-analysis on periodontitis and 
CKD was published in 2013 by Chambrone et al. Their 
findings indicate an increased risk for CKD in the presence 
of periodontitis and a potential beneficial effect of peri-
odontal treatment on glomerular filtration rate (eGFR) [19]. 
In another systematic review, Deschamp-Lenhardt and 
co-workers observed that most of the studies included 
reported increased incidence of periodontitis in CKD 
patients. These authors performed a meta-analysis in which 
a strong association between severe periodontitis and 
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CKD was present (OR = 2.39 [1.70–3.36]) even after 
adjusting for significant risk factors for CKD [20].
In a systematic review from 2018, Kapellas et al. [22] found 
that CKD patients had higher odds of having periodontitis 
(OR = 1.69 [0.84–3.40]). In that same year, a different 
systematic review by Zhao et al. presented results from 38 
studies on the association of periodontitis and CKD, 
including directional and non-directional associations [21]. 
The majority of studies (75%) indicated a significant non-
directional relationship between CKD and periodontitis, 
which was supported by the 2.12 odds ratio resulting from 
the meta-analysis. These authors pointed out that, despite 
the 5 stages of CKD, over half of the studies focused on 
patients with end-stage kidney disease (ESKD) [21].
In 2020, the same group evaluated the effect of periodontal 
treatment in CKD patients in one randomized controlled 
clinical trial (RCT) and four case series, with most studies 
including dialysis patients. The authors found insufficient 
evidence for the beneficial effect of non-surgical periodontal 
treatment in patients with CKD, as evaluated in terms of 
estimated glomerular filtration rate (eGFR) and serum 
creatinine and pointed out the need for more RCTs [23]. 
In contrast, based on results from five RCTs, Yue et al. 
reported a significant moderate reduction of highly sensi-
tive CRP (hsCRP) after non-surgical periodontal treatment 
in haemodialysis and peritoneal dialysis patients [24]. 
Interestingly, malnutrition is a frequent problem faced by 
dialysis patients and data from various studies support a 
link between periodontitis and markers of malnutrition in 
dialysis and haemodialysis patients [25,26].
In conclusion, the current literature supports a moderate to 
strong association between periodontitis and CKD, while 
the potential benefits of periodontal treatment on the 
systemic inflammation in end-stage kidney disease require 
further investigation, potentially due to the limited number 
of interventional studies. The potential link between mal-
nutrition and periodontitis in CKD patients requires further 
investigation.
caries
Caries is the most common NCD globally, leading to 
destruction of dental tissues because of exposure of dental 
surfaces to acids produced by oral bacteria in the presence 
of carbohydrates. Untreated caries can cause pain and 
discomfort associated with cavities, pulpitis (inflammation 
of the dental nerve) and ultimately tooth loss [27]. 
Currently, there is a lack of consensus on the relation- 
ship between caries and CKD, with some investigations 
reporting no differences between healthy people and CKD 
patients [28,29], others reporting a higher prevalence of 
caries [30], and some reporting lower caries prevalence in 
CKD patients [31]. 
In a systematic review and meta-analysis by Limeira et al., 
caries prevalence in adults with CKD and in healthy controls 
was compared; these authors reported lower caries scores 
in CKD patients [32]. Similar findings of lower prevalence 
of caries were reported for children and adolescents with 
CKD in a systematic review by Andrade et al. [33]. The 
higher salivary urea concentration in CKD patients can 
possibly explain the higher capacity for remineralization of 
dental surfaces and lower prevalence of caries [34].
Edentulousness
The number of teeth present has a direct influence on mas-
ticatory function, with the presence of occluding premolar 
and molar teeth being a requirement for adequate mas-
tication. The main causes of tooth loss are periodontitis 
and caries, which have been linked to several conditions 
due to inappropriate diet [35]. One prospective study 
reported a link between edentulousness and increased 
mortality in haemodialysis patients over a 12-month 
period [36]. Similarly, Ruokonen et al. reported fewer teeth 
present in deceased haemodialysis patients, suggesting a 
potential link between tooth loss and CKD [37]. 
Oral mucosal alterations
Oral mucosal lesions are more prevalent in cases of severe 
CKD and these patients are particularly prone to fungal 
infections. In a large study including over 4000 adults on 
haemodialysis, 40% of the sample had at least one oral 
mucosal lesion [38]. In a systematic review on oral lesions 
in CKD patients, oral candidiasis was present in approxi-
mately 20% of adults with stages 1–5, and dialysis and 
oral herpetic lesions were reported in 2.0–2.9% of dialy- 
sis patients [39]. Abnormal lip pigmentation has been 
reported in 48% of patients with end-stage kidney disease 
in whom an association between oral lesions and GFR was 
reported [40].
Uncommon alterations in the oral mucosa of uraemic 
patients include oral ulcers, petechiae, bruises and uraemic 
stomatitis [41]. The last is a specific condition seen in renal 
patients that is due to mucosal irritation by ammonia or its 
compounds. It is typically characterized by white plaques 
on the buccal mucosa, on the floor of the mouth and 
tongue, with pain, bad taste and a burning sensation being 
common symptoms. These lesions tend to improve after 
dialysis and observing oral hygiene with the use of anti-
septic mouthwashes [42]. In kidney transplant patients, oral 
hairy leukoplakia and lichenoid lesions are common in the 
tongue, particularly in patients undergoing cyclosporine 
therapy, presenting as painless white patches with an irreg-
ular surface [41]. 
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Xerostomia
Xerostomia, also known as dry mouth, and reduced salivary 
flow have been reported in 28–59% of ESRD patients, with 
polyuria, medication and alterations in the salivary glands 
being reported as the most common causes [40]. Saliva 
plays a crucial role in the maintenance of oral health. The 
reason why xerostomia decreases patients’ quality of life is 
the associated symptoms of dysphagia, dysgeusia, discom-
fort and increases the risk of infections, caries and peri-
odontitis. Typical signs of xerostomia include glossitis, 
peeling lips, pale oral mucosa and cervical caries [39].
Management of xerostomia includes mechanical stimula-
tion of salivary glands (such as by chewing gum), use of 
saliva substitutes or medication (pilocarpine, angiotensin-
converting-enzyme inhibitors alone or combined with 
angiotensin-receptor blockers). Several medications can 
cause xerostomia, including antihypertensive agents, psy-
chotropic medication, anticholinergic drugs and sympathetic 
agonists [6].
Other oral conditions
Gingival overgrowth can be a side effect of immunosup-
pressive cyclosporine therapy in renal transplant patients or 
of calcium channel blockers in dialysis patients, which might 
require surgical excision of gingival tissues to re-establish 
gingival morphology and improve oral hygiene. Up to 70% 
of patients on cyclosporine can develop gingival overgrowth, 
whereas the prevalence in patients taking calcium channel 
blockers has been reported as 10–20% [43].
Halitosis is mainly caused by volatile sulphur compounds 
(VSCs). In CKD, elevated blood and salivary urea levels 
have been associated with bad breath. Around half of 
dialysis patients present with halitosis; dimethyl sulphide 
and methyl mercaptan have been reported as the most 
prevalent VSCs in CKD-related halitosis. Dialysis can 
improve CKD-related halitosis, as it helps reduce blood 
urea nitrogen levels [44].  
Higher calculus formation has been reported in patients 
with CKD, which has been linked to altered urea con-
centrations, leading to lower salivary pH and increased 
precipitation of calcium and phosphorus, thereby increasing 
calculus formation [36,46]. 
In line with the increased prevalence of oral conditions in 
CKD patients, a recent systematic review investigated oral 
health-related quality of life (OHRQoL) in patients with 
end-stage kidney disease; it reported reduced OHRQoL 
for haemodialysis and renal transplantation patients, sug-
gesting the need for a multidisciplinary care approach [46].
EVIDENcE ON HOW OrAL INFEctIONs 
cAN cONtrIbUtE tO sYstEMIc 
INFLAMMAtION
Chronic diseases, including CKD, share common risk factors 
with periodontitis, including exposure to tobacco, alcohol 
consumption, diabetes, increasing age and poor diet with 
high sugar content [47,48]. In a study by Fisher et al., peri-
odontitis was considered a non-traditional risk factor for 
CKD given the association between the two diseases, 
which remained significant after adjustment for traditional 
risk factors [49]. The mechanisms behind the link between 
periodontitis and systemic conditions include systemic 
inflammation as a result of local inflammation in the peri-
odontal tissues, bacteraemia, endothelial dysfunction and 
potential oral and gut dysbiosis [50].
systemic inflammation
In periodontitis, elevated production of inflammatory medi-
ators such as IL-1β, TNF-α and IL-6 have been reported 
in periodontal tissues, saliva and gingival crevicular fluid 
[51,52]. Increased levels of these markers have also been 
reported in serum, which can lead to raised CRP levels  and 
potential damage to the kidneys, suggesting that locally 
produced cytokines can reach the circulation and contribute 
to systemic inflammation [53]. In a recent study by Rapone 
et al., periodontal status were associated with CRP serum 
levels in haemodialysis patients [54].
Ioannidou and co-workers evaluated the effect of peri-
odontitis on CRP levels of patients with CKD through the 
NHANES III data set. In total, 42% of periodontitis, 27% of 
periodontally healthy patients and 53% of edentulous CKD 
patients had serum CRP above 0.3 mg/dL, suggesting a 
strong association between periodontitis and serum CRP 
levels in CKD [55]. Additional studies support the finding 
of a mild acute-phase systemic inflammatory response 
resulting from periodontitis, as reported in a systematic 
review from Paraskevas et al. [56]. Periodontal treatment 
has been shown to moderately reduce hs-CRP in haemo-
dialysis and dialysis patients [24], although not all studies 
are able to report reduced serum inflammatory markers or 
renal function markers after periodontal treatment [23].
Anaemia is a prevalent finding in CKD patients, and despite 
treatment with erythropoiesis stimulatory agents (ESA), 
some patients fail to improve haemoglobin levels [57]. 
Interestingly, periodontitis has been associated with inflam-
mation-related anaemia in a recent study involving over 
800 patients. Periodontitis was associated with reduced 
haemoglobin, mean corpuscular haemoglobin (MCH) and 
MCH concentration.  In this study, 14–15.7% of periodon-
titis patients presented anaemia according to the WHO 
criteria, whereas 8.4–10.2% of healthy controls were 
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anaemic [58,59]. One of the mechanisms behind anaemia 
and haemoglobin variability in CKD patients treated with 
ESA is cytokine-induced inflammation, which is a shared 
characteristic of CKD and periodontitis. Thus, in anaemic 
CKD patients, oral infections, particularly periodontitis, can 
be a hidden source of inflammation and unresponsive 
haemoglobin levels in ESA-treated patients.
bacteraemia
Another potential explanatory pathway for the influence of 
periodontitis on CKD is the entrance of bacteria or bacterial 
products, such as lipopolysaccharides, through ulcerated 
periodontal tissues into the bloodstream, with the potential 
to cause damage to the kidney endothelium [15].
Several lines of evidence support the role of bacteraemia 
of oral origin in systemic conditions. Certain periodontal 
pathogens, such as Aggregatibacter actinomycetemcomitans 
and Porphyromonas gingivalis, have the ability to invade 
macrophages and/or dendritic cells and escape the host 
response, which could be important in the context of bac-
teraemia [60]. Furthermore, the DNA and RNA of peri-
odontitis bacteria  have been identified in atheromatous 
lesions [61,62]. Levels of circulating bacteria have been 
reported to be higher in systemically healthy patients with 
periodontitis than in gingivitis patients [63]. While the 
immune system of a healthy person is expected to be able 
to eliminate circulating bacteria, bloodstream infections 
lead to higher mortality in CKD patients, particularly end-
stage kidney disease [64]. Collectively, these data suggest 
that bacteraemia can be relevant to the connection 
between systemic inflammation in periodontitis and CKD.
Of note, infective endocarditis (IE), which can lead to renal 
involvement in up to 60% of IE cases and potentially to 
ESRD, can be caused by oral bacteria [65,66]. The most 
common oral bacteria linked to IE are streptococci from 
the viridans group. Dental treatment can potentially cause 
bacteraemia, although the risk is significantly higher for 
toothbrushing [67]. Although toothbrushing and flossing 
can increase the risk of short-term bacteraemia, good 
oral hygiene reduces the risk for IE in the long term [68]. In 
the presence of periodontal disease, the ulcerated gingival 
sulcus is believed to facilitate the entrance of oral strep-
tococci bacteria into the systemic circulation [66]. Good 
oral hygiene and elimination of infection in the oral cavity 
can reduce the bacterial load and help prevent IE from 
oral bacteria.
Endothelial dysfunction
The high risk of cardiovascular disease in CKD patients 
cannot be totally explained by traditional risk factors such 
as diabetes and hypertension. In CKD, endothelial dys-
function increases the risk of cardiovascular disease [69]. 
Periodontitis has been associated with endothelial dys-
function in healthy patients with no cardiovascular risk 
factors and in patients with hypertension. In the presence 
of periodontitis, forearm blood flow responses to acetyl-
choline were significantly reduced compared to subjects 
without periodontitis [70]. These findings have been con-
firmed by another study, in which flow-mediated dilatation 
of the brachial artery was positively associated with peri-
odontitis [71]. Interestingly, periodontal treatment has 
been associated with reduced serum CRP and IL-6 and 
improved acetylcholine-induced vasodilation in systemically 
healthy patients and in patients with hypertension [70], 
which was confirmed by a meta-analysis reporting a bene-
ficial effect of periodontal treatment on endothelial function 
[72]. Hence, endothelial dysfunction could be a biological 
link through which periodontitis contributes to worsening 
of CKD, increasing the risk for cardiovascular disease.
Gut dysbiosis
Gut dysbiosis has been suggested as a novel risk factor for 
the progression and development of complications in CKD 
due its potential to increase systemic inflammation and 
oxidative stress. One of the proposed biological pathways 
for gut dysbiosis in CKD is the disruption of the intestinal 
epithelium and the translocation of uraemic toxins from 
the gastrointestinal lumen to the circulation  [73].
Periodontitis has also been linked to gut dysbiosis resulting 
from ingestion of dysbiotic oral bacteria through swallowed 
saliva. Studies suggest that periodontal pathogens can reach 
the gut and change the local microbiota,  increase gut per-
meability and contribute to endotoxemia and systemic 
inflammation [74]. Indeed, P. gingivalis has shown resistance 
to stomach acids, being able to reach the colon and alter its 
function [75,76]. Under healthy conditions, oral bacteria 
have limited ability to colonize the intestine; however, in 
the presence of certain systemic diseases, such as colon 
cancer and inflammatory bowel syndrome and HIV infec-
tion, oral bacteria have been reported in elevated amounts 
in the gut [77]. 
Given that gut dysbiosis has been linked to malnutri- 
tion [78], and periodontitis has also been associated with 
markers of malnutrition [25,26,79], there is biological 
plausibility in the link between oral diseases, nutrition, gut 
health and general health.  
Lourenço et al. [80] investigated the gut microbiome in 
periodontitis patients and reported less diversity in the 
intestinal microbiome in periodontitis cases compared to 
healthy controls. Furthermore, several oral bacteria asso-
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ciated with periodontal inflammation were identified in the 
gut microbiome of these individuals irrespective of their 
periodontal status [80]. An in vitro study on the periodontal 
pathogens Porphyromonas gingivalis and Prevotella inter-
media suggested that frequent swallowing of dead bacteria 
can affect pathogens in the intestines, resulting in increased 
cytotoxicity and upregulation of virulence genes [81]. 
Thus, despite the limited number of human studies on gut 
dysbiosis in periodontitis patients and on the potential 
mechanisms involved, this is a new area of research which 
can represent a novel pathway for oral bacteria to con-
tribute to systemic inflammation in CKD and other systemic 
diseases [74].
tHE IMPOrtANcE OF PrEVENtION AND 
trEAtMENt OF OrAL cONDItIONs 
FOr PAtIENts WItH cKD
Disease in the oral cavity can impair quality of life, affecting 
important functions such as mastication, digestion and 
speech [82]. The consequences of oral conditions go 
beyond the oral cavity, potentially contributing to increased 
inflammation in the body, as discussed in the previous 
sections. Individuals with CKD are more susceptible to 
infections, the reason why untreated oral conditions, which 
tend to be more prevalent and severe than in the general 
population, can become a source of infection and adversely 
affecting the disease. Dental and medical management of 
patients with CKD can be challenging for several reasons, 
including their increased tendency for bleeding, the addi-
tional risk of infections and interactions between medi-
cations [83]. Frequent dental monitoring is crucial for these 
patients and should be part of a multidisciplinary approach 
to managing CKD and ESKD.
In Table 1 we present a summary of the oral lesions that 
are frequently observed in patients with impaired kidney 
function and the proposed dental and medical approach to 
address these conditions (adapted from Abed et al. [84]).
Oral health and mortality in cKD patients 
Untreated dental conditions and poor oral health can 
contribute to premature death in patients with end-stage 
kidney disease, as reported in a prospective study on 4205 
haemodialysis patients. The mortality  rate was associated 
with edentulism and caries, whereas good oral hygiene 
practices were associated with increased survival [36]. 
These findings were confirmed by another study, in which 
more oral infections and fewer teeth were present in 
deceased pre-dialysis patients [37].
The relation between periodontitis and mortality due to 
cardiovascular disease in haemodialysis patients was inves-
tigated by Kashirsagar et al. [85]. Moderate to severe peri-
odontitis was positively associated with cardiovascular 
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table 1.  Summary of oral lesions in relation to impairment of renal function and the proposed integrated management approach.
Renal function Oral conditions Suggested integrated approach
Removal of metabolic waste
Halitosis – “ammonia breath” can develop due to 
high urea levels combined with poor oral hygiene and 
stomatitis. 
Control of uraemic toxins, improvement in oral hygiene 
habits.
Uraemic stomatitis – white/grey membranes in the oral 
mucosa; can be combined with ulcers, typically painful.
Benzydamine hydrochloride (0.15%) can be prescribed 
to alleviate uraemic stomatitis symptoms. When 
urea levels return to normal, the stomatitis heals 
spontaneously after approximately 3 weeks.
Water and electrolyte balance 
Xerostomia (dry mouth) – saliva flow can decrease 
and salivary glands can become swollen; linked to 
changes in protein and electrolytes. 
Several palliative measures can help patients with 
xerostomia to avoid development of caries and perio-
dontal disease. 
Dental calculus – can result from increased salivary pH 
and altered mineral metabolism.
Frequent professional dental cleaning.
Blood pressure control 
Oral lichenoid reaction – can be a side effect of beta-
blocker medications to control high blood pressure.
No elective dental treatment if blood pressure is 
uncontrolled; emergency dental treatment requires 
liaison with physician. 
Immunosuppressive medication
Gingival overgrowth – can develop in patients taking 
cyclosporine and calcium channel blockers.
Consider change in medication, gingival surgery can 
be required to restore morphology and facilitate oral 
hygiene.
Oral candidiasis – patients can become more 
prone to fungal infections in the mouth after renal 
transplantation.
Topical antifungal therapy for 7–14 days.
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mortality – an association that  remained significant after 
adjusting for smoking, diabetes, hypertension, age and 
gender [85]. These findings were corroborated in the study 
by Sharma et al. [16].
The importance of oral health for peritoneal dialysis and 
haemodialysis
Owing to the higher prevalence of oral infection and other 
conditions in both pre-dialysis and dialysis patients, frequent 
dental follow-ups are essential to reduce the risk of local 
and systemic complications. Prevention and treatment of 
periodontitis needs to be a priority to decrease the inflam-
matory burden. The salivary rate of patients on dialysis and 
haemodialysis can be lower, with xerostomia being a 
frequent finding, which can lead to higher risk of oral 
diseases. It is important to maintain regular dental follow-
ups to manage xerostomia and avoid the consequent 
development of other oral conditions, such as caries and 
periodontitis. Salivary flow has been reported to improve 
after kidney transplantation [86]. Halitosis can be another 
oral condition in uraemic patients (uraemic breath) and 
usually improves after dialysis. 
the importance of oral health for kidney 
transplantation 
Oral infections need to be systematically eliminated before 
kidney transplantation and use of immunosuppressive 
medications. In general, kidney transplant patients have a 
relatively high prevalence of periodontitis and oral con-
ditions. Furthermore, exposure to cyclosporine or calcium 
channel blockers can have side effects on the oral cavity, 
such as gingival overgrowth, leukoplakia, recurrent oral 
ulcers, viral infections, oral candidiasis and malignancies, 
particularly lip cancer [87,88]. Daily oral hygiene can 
become challenging in the presence of gingival overgrowth, 
which can increase the risk of periodontitis and caries [89].
Zwiech et al. reported increased risk of acute rejection 12 
months after kidney transplantation in patients with poor 
oral health, suggesting the potential of poor oral health to 
adversely affect the function of transplanted kidneys [90]. 
Together with medical monitoring, kidney transplantation 
patients require frequent dental monitoring to allow for 
early detection and treatment of oral conditions to avoid 
local and systemic complications [91].
Thus, all stages of CKD require frequent dental follow-ups, 
including preventive and restorative measures, particularly 
ESKD. However, palliative and preventive treatment 
should take place only 6 months after kidney transplanta-
tion, as this is a critical phase for graft rejection and the 
most intensive phase of immunosuppression. No invasive 
dental treatment should be performed before 6 months 
post kidney transplantation [84].
KEY INFOrMAtION AbOUt OrAL 
INFEctIONs IN cKD PAtIENts FOr 
PHYsIcIANs AND NEPHrOLOGIsts
•   There is a relatively high prevalence of oral disease in 
CKD patients, including periodontitis, xerostomia, lower 
salivary flow, calculus, taste disturbances, halitosis 
(uraemic odour), oral mucosal lesions and potentially 
caries. Early detection and treatment can minimize the 
need for comprehensive dental care.
•   Optimal oral hygiene measures are important to reduce 
the bacterial burden associated with the dental biofilm 
and prevent oral infections. Patient motivation to main-
tain adequate daily oral hygiene is critical.
•   The identification of periodontal diseases can be chal-
lenging and requires specific examination with a peri-
odontal probe, which can register gingival bleeding and 
the depth of the gingival pocket in millimetres, revealing 
the severity and extent of the disease. Radiographs can 
also help in the identification of alveolar bone loss, 
resulting from periodontitis. Periodontal treatment can 
potentially help reduce systemic markers of inflammation. 
•   Management of xerostomia includes use of saliva sub-
stitutes and sugar-free chewing gum to increase salivary 
flow, avoidance of mouth breathing, alcohol, tobacco, 
caffeine and alcohol-containing mouthwashes.
•   Mastication can be poor as a result of periodontitis and 
edentulousness, leading to poor nutritional status, which 
is also frequently linked to CKD. Control of oral diseases 
to reduce risk of tooth loss and adequate tooth replace-
ment should be considered to restore masticatory func-
tion in CKD patients.
•   Diagnosis of oral mucosal lesions in CKD may require a 
biopsy to exclude potential malignancies.
•   When preparing patients for kidney transplantation, it is 
crucial for them to undergo thorough screening and 
treatment for oral infections before starting on immuno-
suppressive medications and receiving kidney trans-
plantation.
•   An integrated approach to healthcare in CKD is neces-
sary, with oral health being an essential part of the overall 
medical strategy. Upon referral, the nephrologist should 
inform the dentist about relevant aspects of the patient’s 
medical history, the stage of the disease, current medi-
cations and the latest laboratory test results.
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cONcLUsIONs
CKD is often associated with poor oral health, increased 
prevalence of periodontitis, caries, edentulism, calculus, oral 
mucosal lesions, halitosis and xerostomia. Untreated oral 
conditions can become a source of infection, being detri-
mental to the systemic environment owing to the potential 
to worsen general inflammation, endothelial function, nutri-
tional status, quality of life and mortality in CKD patients. 
Frequent monitoring and treatment of oral infections is 
crucial in CKD patients, particularly prior to renal trans-
plantation. Maintenance of a healthy and functional denti-
tion and periodontium should be an integral part of the 
general medical approach for CKD patients, as it can 
contribute to better nutrition, lower general inflammation 
and infection, improved health outcome and longer survival.
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